DHX9 and lymphoma: p53−/−Eμ-Myc lymphomas were compared to TSC2+/−Eμ-Myc lymphomas – the latter of which were previously characterized and shown to contain functional p53 signaling as well as being highly responsive to DHX9 suppression [18–20].